Dmitry Balyasny’s Lux Health Tech Acquisition Corp. Warrants LUXAW Stock Holding History

Dmitry Balyasny’s Portfolio LUXAW Stock Details LUXAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-414,170	Closed	-$56K	–	3552
2022 Q3	$56K	Hold	414,170	–	–	﹤0.01%	2468
2022 Q2	$55K	Hold	414,170	–	–	﹤0.01%	2348
2022 Q1	$174K	Hold	414,170	–	–	﹤0.01%	2049
2021 Q4	$352K	Hold	414,170	–	–	﹤0.01%	1706
2021 Q3	$476K	Hold	414,170	–	–	﹤0.01%	1493
2021 Q2	$547K	Buy	414,170 +191,548	+86%	+$254K	﹤0.01%	1531
2021 Q1	$332K	Buy	+222,622	New	+$561K	﹤0.01%	1480

Dmitry Balyasny's LUXAW Position: Q4 2022 in Review

Dmitry Balyasny sold out of Lux Health Tech Acquisition Corp. Warrants (LUXAW) in Q4 2022, closing a stake of 414,170 shares — an estimated $56K sold.

Dmitry Balyasny first reported a position in LUXAW in Q1 2021 and held it in 7 quarters. The position peaked at $547K in Q2 2021. 0 funds tracked by Wall St. Rank hold LUXAW as of Q4 2022.

Dmitry Balyasny reported no remaining Lux Health Tech Acquisition Corp. Warrants position as of Q4 2022 after selling out during the quarter.
Dmitry Balyasny sold 414,170 Lux Health Tech Acquisition Corp. Warrants shares in Q4 2022, an estimated $56K.
Dmitry Balyasny first reported a position in Lux Health Tech Acquisition Corp. Warrants in Q1 2021 and held it in 7 quarters.
Dmitry Balyasny's Lux Health Tech Acquisition Corp. Warrants position peaked at $547K in Q2 2021.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Warrants as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.